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To detect its cognate antigen, each B lymphocyte contains up to 120 000 B cell antigen receptor (BCR)
complexes on its cell surface. How these abundant receptors remain silent on resting B cells and
how they can be activated by a molecularly diverse set of ligands is poorly understood. The anti-
gen-speciﬁc activation of the BCR is currently explained by the cross-linking model (CLM). This
model predicts that the many BCR complexes on the surface of a B cell are dispersed signalling-inert
monomers and that it is BCR dimerization that initiates signalling from the receptor. The ﬁnding
that the BCR forms auto-inhibited oligomers on the surface of resting B cells falsiﬁes these predic-
tions of the CLM. We propose the dissociation activation model (DAM), which ﬁts better with the
existing body of experimental data.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mature B cells sense pathogens through the B cell antigen
receptor (BCR), which is expressed in large numbers on their sur-
face. The BCR is composed of the membrane-bound immunoglob-
ulin (mIg) molecule and a heterodimer of the Iga (CD79a) and
Igb (CD79b) protein [1]. The evolutionarily conserved cytoplasmic
tails of Iga and Igb are essential for the signalling function of the
BCR and both contain an immunoreceptor tyrosine-based activa-
tion motif (ITAM) [2]. A deletion or mutations in these tails render
the BCR signalling-inert [3,4]. The two tyrosines of the ITAM se-
quence are targets of protein tyrosine kinases of the Src and spleen
tyrosine kinase (Syk) family. Speciﬁcally, the Src-family kinase Lyn
phosphorylates and interacts dominantly with the ﬁrst ITAM tyro-chemical Societies. Published by E
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el.reth@bioss.uni-freiburg.desine, whereas the Syk phosphorylates both ITAM tyrosines, thus
creating docking sites for its two tandem Src homology 2 (SH2) do-
mains [5,6]. Similar to Lyn, Syk is an allosterically regulated en-
zyme. The two tandem SH2 domains, the linker regions
connecting the SH2 domains and the kinase domain (interdomain
A and B) are involved in the inhibition of the Syk kinase activity [7].
The molecular details of this auto inhibition have been revealed by
the crystal structure of the Syk family kinase Zeta-chain-associated
protein kinase 70 (ZAP70) [8]. The auto inhibition of ZAP70 and Syk
ensures that these kinases only become active once they bind a tar-
get protein that, in most cases, carries an ITAM sequence. When
bound to the BCR, Syk remains active and phosphorylates several
key components of intracellular signalling pathways, including
the adaptor proteins SH2 domain-containing leukocyte protein of
65 kDa (SLP-65, also called BLNK, B-cell linker) and B-cell adapter
for phosphoinositide 3-kinase (PI3K) (BCAP). In this way, BCR sig-
nals are connected to Ca2+ release and the PI3K pathways, respec-
tively. Furthermore, Syk bound to one BCR complex can rapidly
phosphorylate the ITAMs of neighboring BCR complexes, thus
resulting in signal ampliﬁcation [9]. However, this signal spreading
seems to be possible only between BCRs of the same Ig class
[10,11]. In general, we presently know more about the function
of the BCR on activated B cells and this knowledge has been re-
cently summarized in several excellent reviews [12–14]. However,
without knowing more about the structure and regulation of the
BCR on resting B cells, our view of the BCR activation process re-
mains incomplete. We propose here that the BCR has an auto-
inhibitory structure on resting B cells and that BCR signalling is
regulated through the control of ITAM accessibility.lsevier B.V. All rights reserved.
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The CLM is one of most successful hypothesis in cell biology and
is an integral part of many biological textbooks. It was formulated
as a simple and universal mechanism for how receptors are acti-
vated on the cell surface, long before detailed knowledge about
the structure and signalling mechanism of most receptors was ob-
tained. This hypothesis states that receptors on the cell surface are
dispersed monomers and that signalling occurs whenever two or
more of these monomers are cross-linked together, for example
by a bivalent ligand. One prominent class of receptors that are
thought to be activated by cross-linking are members of the tyro-
sine kinase receptor family, such as the epidermal growth factor
receptor (EGFR) and insulin receptor (IR). Indeed, it has been
shown that the kinase domain of these receptors is activated by re-
ciprocal trans-phosphorylation, ﬁtting with the CLM [15]. One
problem was, however, that some of the active ligands (i.e., EGF)
are not really dimers. How could they then cross-link these recep-
tors? One solution to this problem came from the analysis of the
crystal structure of the ectodomain of these receptors. It was found
that in addition to the inactive monomer form, EGFR are also ex-
isted as dimers that reside in an auto-inhibitory conformation
[16]. Binding to EGF resulted in the stabilization of an altered con-
formation that brought the two kinase domains in close proximity
to each other, thus allowing their reciprocal phosphorylation and
activation [17]. In the meantime, IR was found to be a dimeric, allo-
steric membrane receptor. Inactive IR dimers are in equilibrium
with active dimers. Insulin binding stabilizes the active dimeric
state leading to activation [18]. Higher ordered structures (dimers,
trimers, oligomers) have now been found to be the organizational
principle of many classes of receptors on resting cells [15,19–21]. It
is therefore thought that when cross-linking plays a role in the
activation of these receptors, it is in most cases accompanied by
conformational changes or reorganization of the receptor.
From the beginning, CLM was also an attractive model to ex-
plain the early events accompanying BCR activation. Firstly, it ex-
plained well the results of experiments using anti-receptor
antibodies for BCR stimulation. Here, it was found that only biva-
lent F(ab)2 antigen binding fragments but not monovalent Fab
fragments of anti-receptor antibodies could activate signalling
from the BCR [22]. Similar results where obtained from experi-
ments with monovalent and polyvalent antigens although these
results were not always clear-cut as sometimes a large monovalent
antigen could also activate the BCR without apparent cross-linking
[23–25]. These experiments were taken as proofs that cross-linking
is the major mechanism of BCR activation, although other BCR
model could explain these data as well (see below). Secondly, the
analysis of the crystal structure of the antibody molecules revealed
the existence of a ﬂexible hinge region situated between the Fab
and the constant parts (Fc) of this molecule [26]. It was discussed
that this hinge should prevent the transfer of conformational alter-
ations from the Fab to the Fc part of the antibody, thus excluding a
role of conformational changes in BCR activation. The CLM did not
require a conformational change of the BCR, thus taking care of this
problem.
Upon closer examination, the CLM has several problems. First,
from receptors that are activated by cross-linking, it is known that
the spacing of the two receptors is highly critical for signalling.
Therefore, these receptors often have precisely spaced dimeriza-
tion structures that are activated by binding of their cognate li-
gands [27,28]. The BCR differs from these receptors in that it
does not have one deﬁned ligand. Rather the BCR can be activated
by thousands of structurally different ligands. How this diverse li-
brary of ligands could always place two BCR-complexes at the right
distance preferred for signalling is not clear and we referred to thisas an unsolved problem of the clonal selection theory of Burnet
[29].
Second, the CLM assumes that the reciprocal phosphorylation of
ITAM-bound Syk is a critical step for BCR activation. However, this
assumption is not supported by current data showing that Syk is
already released from auto-inhibition and active just by binding
to one ITAM [30,31]. A monomeric BCR is therefore perfectly able
to activate Syk without cross-linking as long as its ITAM tyrosines
are accessible. Furthermore, each monomeric BCR carries two
ITAM sequences, namely that of Iga and Igb, and thus could place
two Syk molecules in close proximity to each other even without
cross-linking.
Third, the CLM assumes that the numerous BCR complexes on
the B cell surface are monomers but this assumption has never
been rigorously proven and recent experiments do not support this
assumption (see below).
Fourth, the CLM does not attribute any role to the evolutionarily
highly conserved amino acids in the transmembrane (TM) region of
the mIg molecule, apart from those involved in the binding of the
Iga/Igb heterodimer [32].
In spite of its original success in explaining the activation of the
BCR in the context of the activation process of other receptors, in
the case of the BCR, the CLM is a failing model that is no longer
in line with the current experimental data on this receptor.
3. Dissociation activation model (DAM) and the oligomeric BCR
on resting B cells
In an effort to study the structure of the BCR complex, we used
blue native polyacrylamide gel electrophoresis (BN-PAGE), a meth-
od that was successfully employed to identify components of
supramolecular protein complexes in the membrane of mitochon-
dria [33]. In the BN-PAGE analysis, we found that under low-per-
centage detergent-lysate conditions, the BCR of class IgM and IgD
runs as large macro-molecular complex [10]. Furthermore, we
showed that in the case of the IgD–BCR, the size of these complexes
was inﬂuenced by alterations of conserved amino acids in the TM
region of the dm molecule, indicating that these TM amino acids
play a role in BCR oligomerization. Based on these and additional
functional data, we suggested that the BCR on resting B cells is
an oligomer and that it is the opening of these oligomers that
drives BCR activation [32]. This suggestion, which relied mainly
on biochemical studies, was not well accepted by the research ﬁeld
and mostly regarded as an artifact of detergent lysis.
The challenge was then to study the behavior of the BCR on the
surface of living cells. To take up this challenge, we tried several
experimental approaches including chemical cross-linking and
the Förster resonance energy transfer (FRET) methods using cyan
ﬂuorescent protein (CFP) and yellow ﬂuorescent protein (YFP)
tagged BCR components and the results were not clear-cut due
to the limitations of the techniques. The FRET method was also
used by Tolar et al. to study the organization of BCR on living cells
[34]. However, while FRET can be a useful method to study the
interaction inside a deﬁned heterodimer, it could be quite prob-
lematic in studying a large protein complex, where CFP and YFP
tagged components are not always next to each other and where
the donor/acceptor ratio can be variable. Furthermore, FRET only
allows for conﬁrmation but does not rule-out a protein–protein
interaction as there can be many reasons for a low FRET value apart
from the absence of an interaction [35]. For example, if the two
ﬂourophores were oriented perpendicular to each other, there will
be no FRET between CFP and YFP even if they are close enough.
To learn more about the organization of the BCR on living cells,
we combined three different techniques [36]. One was a synthetic
biology approach, namely, rebuilding the BCR on the surface of a
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biﬂuorescence complementation assay (BiFC) allowing for the
detection of BCR dimerization via the generation of ﬂuorescent
form of a complemented ﬂuorescent protein [37]. The third meth-
od was based on the immunoprecipitation of multiprotein com-
plexes detected by ﬂow cytometry (IP-FCM), a technique that
allows quantitative FACScan analysis of different components in
a large protein complex following immunoprecipitation on beads
[38]. For the BiFC experiments, we fused half-domains of YFP and
CFP (YN and CC) to either Iga and Igb or to two different Iga pro-
teins. This allowed us to test either for Iga/Igb heterodimerization
or for BCR oligomerization. Once brought together, the YN or CC
half-domains form a cYFP ﬂuorophore, the generation of which
can be monitored in living cells and quantiﬁed by IP-FCM. This
analysis showed that BCR oligomerization is an efﬁcient and spon-
taneously occurring process on the surface of living S2 and B cells.
Having developed a readout for BCR oligomerization, we were able
to identify an IgD–BCR mutant that is defective in this process. The
monomeric BCR mutant carries alterations in the class-speciﬁc side
of the TM-region of mIgD and lacks the disulﬁde bridge between
Iga and Igb. As previously shown by BN-PAGE [10], this indicates
that the conserved amino acids at the TM-region of mIgD are in-
volved in the oligomerization process. Furthermore, removing the
disulﬁde bridge between Iga and Igb may alter the conformation
of this heterodimer and this could interfere with BCR oligomeriza-
tion. This monomeric BCR mutant was found to be more active and
less stably expressed on the B cell surface, suggesting that BCR
complexes within oligomers are more ordered and that BCR activa-
tion may be driven by increasing entropy according to the second
law of thermodynamic. Indeed we found that, compared to a BCR
wild-type control, a BiFC-stabilized BCR-dimer is less well internal-
ized and less active in signalling. From these experiments, we con-
clude that tight oligomers are the auto-inhibited form of the BCR
and proposed with DAM a new model for BCR activation (Fig. 1).
According to DAM, most BCR complexes forms auto-inhibited olig-
omers in the membrane of resting B cells. Right now, the nomen-
clature for ‘‘BCR oligomer” is not clearly deﬁned. We thus
suggest using the term ‘‘BCR oligomer” exclusively for the descrip-
tion of these auto-inhibited oligomers in the resting stage of the
BCR. Upon antigen-binding, the BCR forms clusters of active mono-
mers and we suggest to refer to these activated form of the BCR as
active BCR clusters. It is feasible that within the BCR oligomer, both
the conserved class-speciﬁc amino acids in the TM-region of mIgD
and the ITAM tyrosines are engaged in interactions and thus difﬁ-
cult to access. A polyvalent antigen binding to mIg can interfere
with the formation or promote the dissociation of the BCR oligo-Fig. 1. Schematic drawing of the dissociation activation model (DAM). According to this
structure, the ITAM tyrosines are not accessible to kinase (closed). In the presence of antig
the open clustered monomers. The dissociation of BCR oligomers leads to B cell activatimer. Importantly, the dissociation process does not require a pre-
cise structure of the antigen. The BCR dissociation can thus have
two consequences: it should make the Iga/Igb tails more accessible
for phosphorylation and it may expose the conserved class-speciﬁc
amino acids of the TM region of the mIg molecule to the lipid envi-
ronment. The latter event could result in changes of the lipid shell
surrounding the BCR and help to target the receptor to other mem-
brane areas, which are more prone to signalling, such as lipid rafts
[39]. Such changes in the lipid environment of the BCR have re-
cently been detected by a FRET study [40]. According to DAM, it
is the dissociation of the BCR oligomer that drives activation. This
dissociation may not only involve individual BCR complexes but
also negative regulatory proteins that help the BCR to stay silent
on resting B cells (see below).
4. Protein island and membrane receptor regulation
Many recent studies suggest that the plasma membrane is more
structured than originally postulated by the ﬂuid-mosaic-model
[41]. In particular, signal-particle tracking techniques have shown
that the lateral diffusion of membrane proteins is restricted to
nanometer-scale conﬁnement zones [42]. A membrane-skeleton
fence (picket fence) model has been proposed to explain this con-
ﬁned diffusion [43]. According to this model, small membrane
patches are surrounded by components of the cytoskeleton that
limit the diffusion of associated membrane proteins to a nanome-
ter space. These conﬁnement zones could have different purposes.
For example, they could contain lipid rafts and promote localized
signalling events. Other conﬁnement structures may be more asso-
ciated with the signalling-inert receptor. In this respect, it is inter-
esting that recent studies on the T cell antigen receptor (TCR) have
suggested that on resting T cells, the TCR resides in protein islands
and that, in these islands, the receptor is kept signalling-inert [44].
How the detected TCR oligomer [20] can be related to these struc-
tures requires further studies. Studies on the high-afﬁnity IgE
receptor (FceRI) have also shown that the diffusion of this receptor
is limited by actin containing cytoskeleton structures [45].
The group of Batista has found that members of the ezrin–radix-
in–moesin (ERM) protein family could restrict the diffusion of the
BCR [46]. ERM proteins comprise an N-terminal FERM domain that
can bind to adaptors or receptor tails, an alpha-helical connecting
domain and an F-actin binding C-ERMAD domain [47]. These pro-
teins can thus connect receptor or membranes to the actin cyto-
skeleton. In resting B cells, the ERM protein ezrin is associated
with lipid rafts [48]. Upon BCR ligation, this protein is rapidly
dephosphorylated on threonine 567 in the C-ERMAD domain. Thismodel the BCR has an auto-inhibitory oligomeric structure on resting B cells. In this
en, the equilibrium between closed BCR oligomers and monomers is shifted towards
on.
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ently allows the BCR to move into lipid raft structures [49]. A sim-
ilar process occurs in activated T cell where ERM protein
dephosphorylation and the resulting cytoskeleton relaxation pro-
mote the formation of an immunological synapse between the T
cell and the antigen presenting cell [50]. The ERM proteins may
thus be part of the boarders that surround the nano-scale conﬁne-
ment zones of antigen- and Fc-receptors. Following detachment of
the ERM proteins from the membrane, the antigen receptors could
become more mobile and form the signalling-active micro-clusters
that have been found on activated T and B cells.Fig. 2. PRMT1 as an inhibitor and modulator of BCR signalling. In resting B cells,
PRMT1 methylates a conserved arginine (R) at the tail of Iga. This modiﬁcation
interferes with the recruitment of the kinase Syk to the ITAM of Iga and inhibits
signalling from the BCR. PRMT1 also methylates two R of the transcription factor
FOXO1. This modiﬁcation prevents the phosphorylation of FOXO1 by PKB that
results in FOXO1 destruction. In this way, FOXO1 counteracts PI3 kinase signaling
and promotes the differentiation of pre-B cells.
Fig. 3. Model of BCR silencing complexes on the membrane of B cells. According to the
scaled conﬁnement zones. In these areas, the autoinhibtory oligomeric BCR maybe surr
PRMT1. The dissociation from these inhibitory zones can result in a change of the lipidThe model that the cytoskeleton guards receptors on resting
cells is supported by the ﬁnding that signalling is induced after
the treatment of cells with the F-actin inhibitor Latrunculin A
(LatA) [51,52]. The group of Batista showed that LatA treatment re-
sults in an increased mobility of BCR complexes and associates BCR
mobilization with increased signalling [46]. This is somewhat in
conﬂict with data of Liu et al. that suggest that the degree of BCR
immobilization is a readout for the strength of BCR signalling
[53]. However, it is feasible that these opposite behaviors only re-
ﬂect different phases of BCR signalling. After the dissociation of
auto-inhibited BCR oligomers, BCRs may release from its cytoskel-
eton and move out of the conﬁnement zone, results in an increased
BCR mobilization at the beginning. At a later time point, the acti-
vated BCR may regain contact with the cytoskeleton and this
may be important for the prolonged signalling of the receptor. In
this context, it is interesting that the ERM protein ezrin carries
two tyrosines in an ITAM like sequence that become phosporylated
in the course of B cell activation [54]. Thus, it is feasible that tyro-
sine phosphorylated ezrin re-associates with the active BCR and
promotes its immobilization.
5. A glimpse at the silenced BCR complex
How are the new ﬁndings of higher membrane organizations
related to our model of an auto-inhibited BCR oligomer? If the
numerous BCR complexes on the surface of resting B cells are in-
deed conﬁned in nano-scale membrane patches, one could wonder
how the many monomeric BCR that are predicted to exist by the
CLM, are prevented from signalling in these crowded areas. The
formation of auto-inhibited BCR oligomers, on the other hand,
could be favored by BCR crowding in nano-scale conﬁnement
zones on the surface of resting B cells. The oligomeric structure
of the resting BCR may also prevent the uncontrolled release of
the receptors from theses conﬁnement zones. Furthermore, the
bordering cytoskeleton elements might be in direct contact with
the BCR oligomer, thus controlling the accessibility of the ITAM-
containing sequence of the receptor as discussed above. An emerg-
ing scheme is that, on resting lymphocytes, elements activating
signalling are excluded from the antigen receptor conﬁnement
zone as has been found to be the case for LAT [55,56]. In addition,
the conﬁnement zones may promote the association of the antigen
receptor with negative regulators. In this context, we have recentlyprotein island model, most BCR complex on the surface of a B cells reside in nano-
ounded by certain lipids and colocalized with negative regulatory proteins such as
environment and BCR activation.
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co-localized with the resting BCR. The cytosolic tail of Iga carries
a highly conserved arginine (R198), which is methylated by PRMT1
on resting B cells [57]. Interestingly, R198 methylation inhibits sig-
nalling from the BCR (Fig. 2). PRMT1 is known as a negative regu-
lator in different microenvironments, both in the nucleus as well as
in the cytosol. For example, by methylating arginines at tails of his-
tones, PRMT1 inhibits gene expression. By methylating arginines of
Forkhead box O1 (FOXO1), PRMT1 prevents protein kinase B (PKB)
mediated phosphorylation and destruction of this differentiation
factor via the PI-3 kinase pathway [58,59]. Upon BCR activation,
PRMT1 dissociates from the BCR and R198 is rapidly demethylated.
The R198 methylation is the ﬁrst protein modiﬁcation found to be
associated with the resting BCR. We think that the identiﬁed BCR/
PRMT1 association is only a ﬁrst glimpse at BCR silencing com-
plexes that maybe assembled in the conﬁnement zones of resting
B cells around the auto-inhibited BCR oligomers (Fig. 3).
In recent years, the focus of research was primarily on the active
antigen receptors. As deregulated and hyperactive BCR antigen
receptors are associated with several human diseases from autoim-
munity to B lymphomas [60–65], it is clearly important to learn
more about the structure and function of these receptors in its rest-
ing state. How to keep antigen receptors silent therefore, will be a
major focus of research in years to come. Synthetic biology ap-
proaches and the new molecular tools provided by this scientiﬁc
endeavor may be the key elements to shed more light on this as-
pect of B cell regulation.
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